Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Operation Goidpill

Executive Summary

FDA health care fraud operation has resulted in criminal charges against 271 individuals or companies and 176 convictions to date, Joe Ford, of the FBI's White Collar Crimes Section, reports to the National Health Lawyers Association Sept. 27. The project has netted $6.6 mil. in forfeited assets returned to the government plus $6.8 mil. in paid fines. Operation Goidpill, involving investigations of drug diversion, fraudulent billing, and money-laundering, became public on June 30, 1992 when a nationwide sweep resulted in the arrest of more than 100 individuals ('The Pink Sheet" July 6, 1992, p. 3).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel